.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Merck
UBS
Deloitte
McKesson
Argus Health
Cantor Fitzgerald
QuintilesIMS
Express Scripts
US Army

Generated: June 25, 2017

DrugPatentWatch Database Preview

BEROCCA PN Drug Profile

« Back to Dashboard

What is the patent landscape for Berocca Pn, and what generic Berocca Pn alternatives are available?

Berocca Pn is a drug marketed by Roche and is included in one NDA.

The generic ingredient in BEROCCA PN is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e profile page.

Summary for Tradename: BEROCCA PN

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN E') AND hsdb_dru' at line 1
Patents:0
Applicants:1
NDAs:1